Research Progress of Cuttlebone in the Treatment of Chronic Atrophic Gastritis

Author:

Jia Yu,Li Yun,Xu Yongpan

Abstract

As a common disease of digestive system, atrophic gastritis has the characteristics of high incidence, lingering condition, complex mechanism, and can be further developed into gastric cancer. Western medicine can not reverse the transformation of the disease at present, while traditional Chinese medicine can better improve the clinical symptoms and improve the quality of life through individualized treatment. Chinese medicine cuttlebone has the effects of acid pain relief, convergence hemostasis, bacteriostasis, dampness and sore astringency. It is a commonly used Chinese medicine for the treatment of chronic atrophic gastritis. At present, the research on cuttlebone is mostly focused on clinical efficacy, and the mechanism of action is less. Therefore, this paper reviews the research progress of cuttlebone in the treatment of chronic atrophic gastritis in combination with pharmacological research, famous doctor experience and data mining, so as to provide reference for the future research and treatment of chronic atrophic gastritis.

Publisher

Century Science Publishing Co

Reference67 articles.

1. Lin X K, Wang W L. Analysis of high risk factors for chronic atrophic gastritis[J]. Saudi Journal of Gastroenterology, 2023, 29(2):127-134.

2. Huang Xiaoyin. Analysis of the prevalence characteristics and related influencing factors of chronic atrophic gastritis in the high incidence area of gastric cancer in Fujian Province [D]. Fujian Medical University, 2021.

3. Wang Haijian. Application of mosapride combined with rebamipide in chronic atrophic gastritis [J]. Journal of Henan Medical College, 2022, 34 (06): 673-676.

4. Abosheaishaa Hazem, Nassar Mahmoud, Ghallab Muhammad, et al. Pernicious Anemia and Vitamin B12 Deficiency Presenting As Pseudothrombotic Microangiopathy and Developing Secondary Thrombocytopenia After Treatment: A Case Report. [J]. Cureus, 2022, 14(12):2-6.

5. Analysis of the prevalence of malignant tumors in China in 2015 [J]. Chinese Journal of Oncology, 2019, 41 (01): 19-28.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3